Metastatic melanoma to the vagina: Clinicopathologic and immunohistochemical study of three cases and literature review

International Journal of Gynecological Pathology

Volumn 22, Issue 2, 2003, Pages 136-140

  Gupta, Deepali ^a   Neto, Antonio G ^a   Deavers, Michael T ^b   Silva, Elvio G ^b   Malpica, Anais ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Melanoma immunohistochemistry; Metastasis; Tumors; Vagina

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DACARBAZINE; INTERFERON; INTERLEUKIN 2; LEUPRORELIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; TAMOXIFEN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VINBLASTINE;

ADULT; AGED; ANAMNESIS; ARTICLE; BIOPSY; BRAIN INJURY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CASE REPORT; CLINICAL FEATURE; DEATH; EPITHELIOID CELL; FEMALE; FOOT; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MELANOMA; METASTASIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; VAGINA BLEEDING; VAGINA CANCER; VULVA; VULVA PRURITUS;

ADULT; AGED; ANTIGENS, NEOPLASM; DNA-BINDING PROTEINS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; S100 PROTEINS; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; VAGINAL NEOPLASMS;

EID: 0037377647     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200304000-00004     Document Type: Article

References (18)

1. Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994;171:1225-30.
2. Chung A, Casey MJ, Flannery JT, et al. Malignant melanoma of the vagina: report of 19 cases. Obstet Gynecol 1980;55:720-7.
3. Skowronek J, Roszak A. A case of metastatic malignant melanoma of the vagina with a background of primary vaginal melanoma - clinical case. Ginekol Pol 1997;68:390-3.
4. Hsu S, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-21.
5. Chagpar A, Kanthan SC. Vaginal metastasis of colon cancer. Am Surg 2001;67:171-2.
6. Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984;53:1978-84.
7. O'Reilly AP, McLeod F, Craft I. Hypernephroma presenting as a vaginal metastasis. Case report. Br J Obstet Gynaecol 1984;91:812-5.
8. Ovesen H, Gerstenberg T. Vaginal metastasis as the first sign of renal cell carcinoma. A case report and review of the literature. Scand J Urol Nephrol 1990;24:237-8.
9. Pineda A, Sall S. Metastasis to the vagina from carcinoma of the breast. J Reprod Med 1978;20:243-5.
10. Chagpar A, Kanthan SC. Vaginal metastasis of colon cancer. Am Surg 2001;67:171-2.
11. Vanstapel MJ, Gatter KC, de Wolf-Peeters C, et al. New sites of human S-100 immunoreactivity detected with monoclonal antibodies. Am J Clin Pathol 1986;85:160-8.
12. Takahashi K, Isobe T, Ohtsuki Y, et al. Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch B Cell Pathol Incl Mol Pathol 1984;45:385-96.
13. Blessing K, Sanders DS, Grant JJ. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998;32:139-46.
14. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996;20:1489-500.
15. Busam KJ, Chen YT, Old LJ, et al. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 1998;22:976-82.
16. Hofbauer GF, Kamarashev J, Geertsen R, et al. Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. J Cutan Pathol 1998;25:204-9.
17. Hemesath TJ, Steingrimsson E, McGill G, et al. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 1994;8:2770-80.
18. King R, Googe PB, Weilbaecher KN, et al. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol 2001;25:51-7.